Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa511.
Graves' disease (GD) is a typical organ-specific autoimmune disease. Intestinal flora plays a pivotal role in immune homeostasis and autoimmune disease development. However, the association and mechanism between intestinal flora and GD remain elusive.
To investigate the association and mechanism between intestinal flora and GD.
We recruited 58 initially untreated GD patients and 63 healthy individuals in the study. The composition and metabolic characteristics of the intestinal flora in GD patients and the causal relationship between intestinal flora and GD pathogenesis were assessed using 16S rRNA gene sequencing, targeted/untargeted metabolomics, and fecal microbiota transplantation.
The composition, metabolism, and inter-relationships of the intestinal flora were also changed, particularly the significantly reduced short-chain fatty acid (SCFA)-producing bacteria and SCFAs. The YCH46 strain of Bacteroides fragilis could produce propionic acid and increase Treg cell numbers while decreasing Th17 cell numbers. Transplanting the intestinal flora of GD patients significantly increased GD incidence in the GD mouse model. Additionally, there were 3 intestinal bacteria genera (Bacteroides, Alistipes, Prevotella) could distinguish GD patients from healthy individuals with 85% accuracy.
Gut dysbiosis contributes to a Treg/Th17 imbalance through the pathway regulated by propionic acid and promotes the occurrence of GD, together with other pathogenic factors. Bacteroides, Alistipes, and Prevotella have great potential to serve as adjunct markers for GD diagnosis. This study provided valuable clues for improving immune dysfunction of GD patients using B. fragilis and illuminated the prospects of microecological therapy for GD as an adjunct treatment.
格雷夫斯病(GD)是一种典型的器官特异性自身免疫性疾病。肠道菌群在免疫稳态和自身免疫性疾病发展中起着关键作用。然而,肠道菌群与 GD 之间的关联和机制仍不清楚。
探讨肠道菌群与 GD 之间的关联和机制。
我们招募了 58 例初诊未经治疗的 GD 患者和 63 例健康对照者。通过 16S rRNA 基因测序、靶向/非靶向代谢组学和粪便微生物移植,评估 GD 患者肠道菌群的组成和代谢特征,以及肠道菌群与 GD 发病机制的因果关系。
肠道菌群的组成、代谢和相互关系也发生了改变,特别是短链脂肪酸(SCFA)产生菌和 SCFAs 显著减少。脆弱拟杆菌 YCH46 株可产生丙酸,增加 Treg 细胞数量,减少 Th17 细胞数量。移植 GD 患者的肠道菌群可显著增加 GD 小鼠模型的 GD 发生率。此外,有 3 个肠道细菌属(拟杆菌属、alistipes 属、普雷沃氏菌属)可将 GD 患者与健康对照者区分开来,准确率为 85%。
肠道菌群失调通过丙酸调节的途径导致 Treg/Th17 失衡,促进 GD 的发生,同时还有其他致病因素。拟杆菌属、alistipes 属和普雷沃氏菌属具有作为 GD 辅助诊断标志物的巨大潜力。本研究为使用脆弱拟杆菌改善 GD 患者免疫功能提供了有价值的线索,并阐明了微生态疗法作为辅助治疗 GD 的前景。